|
FOR IMMEDIATE RELEASE
Orthomolecular Medicine News Service, May 11, 2020
World-Wide Nutritional Immunity
Why everybody, everywhere is taking vitamin C
Commentary by Andrew W. Saul, Editor-in-Chief
(OMNS May 11, 2020) "Vitamin C protects against coronavirus." The Orthomolecular Medicine News Service first said so on January 26. The opening sentence of that release was and remains politically incorrect: "The coronavirus pandemic can be dramatically slowed, or stopped, with the immediate widespread use of high doses of vitamin C." The next two sentences are virtually never quoted. "Physicians have demonstrated the powerful antiviral action of vitamin C for decades. There has been a lack of media coverage of this effective and successful approach against viruses in general, and coronavirus in particular."
Shortly after this release, CDC and WHO put up statements at their respective websites declaring that vitamin C was useless against COVID-19. Without even checking sources, USA Today and other newspapers declared it "fake news" and "false information." YouTube deleted videos of licensed physicians supporting therapeutic or even preventive use of vitamin C. Facebook literally blocked and banned this quote from one physician with over 30 years' experience treating viral illnesses:
"I have not seen any flu yet that was not cured or markedly ameliorated by massive doses of vitamin C."
(Robert F. Cathcart, MD)
But something else, something big, also happened. OMNS Chinese edition editor Richard Cheng, MD, PhD, was already in place in China. He was first to report in on several Chinese doctors' initial successes using intravenous vitamin C against COVID. This was followed by OMNS publishing quotes from seminars and interviews with these doctors. Videos of these physicians have been promptly and repeatedly removed by YouTube for "violating their community standards."
In spite of this, with no help from the network news, or the NIH, or the CDC, and certainly not from WHO, the public nevertheless drew a vital conclusion: if high dose intravenous vitamin C is useful for treating COVID-19 in hospitalized, ICU patients, then moderate oral doses of vitamin C will likely be a good preventive. Almost immediately, vitamin C sold out worldwide. Shelves were empty. Even the largest retailers were backordered for weeks. Some still are.
Practically the whole world is now taking vitamin C. I think this is the real reason why COVID-19 will not become COVID-20. Or 21.
All OMNS releases on COVID-19 follow below. They are all free access and may be freely reprinted with attribution.
(Andrew W. Saul founded the peer-reviewed Orthomolecular Medicine News Service in 2004 at the request of Abram Hoffer, MD, PhD, and Hugh D. Riordan, MD. Saul, Dr. Hoffer's coauthor for four books, has written, coauthored, or edited twenty-one more. He has no financial connection whatsoever with the supplement industry. )
| Release # | Date | Subject |
|---|
| Vol. 16, No. 28 |
May 4, 2020 |
Vitamin C and Coronavirus: Not a Vaccine; Just a Humble Cure
 Vitamine C et Coronavirus - Pas de vaccin, seulement une humble cure
|
| Vol. 16, No. 27 |
April 30, 2020 |
Protected Group Immunity, Not a Vaccine, is the Way to Stop the COVID-19 Pandemic
La Protection par Immunité de groupe, non par vaccin, est le moyen d'arrêter la pandémie de COVID-19
|
| Vol. 16, No. 25 |
April 23, 2020 |
Vitamin C Evidence for Treating Complications of COVID-19 and other Viral Infections
Preuves de la Vitamine C, pour le traitement des complications de la COVID-19 et d'autres infections virales
|
| Vol. 16, No. 23 |
April 9, 2020 |
Vitamin D Supplements Could Reduce Risk of Influenza and COVID-19 Infection and Death
La Supplémentation en Vitamine D pourrait réduire les risques de Grippe, d'Infection par COVID 19 et de Décès
 Vitamin D könnte das Infektions- und Sterberisiko durch Influenza und COVID-19 verringern
 L'integrazione di Vitamin a D potrebbe diminuire il rischi o di infezione e mortalità per i nfluenza e COVID 19
|
| Vol. 16, No. 22 |
April 4, 2020 |
Sulforaphane as a Treatment for COVID-19
Sulforaphane comme Traitement du COVID-19
Sulforaphan zur Behandlung von COVID-19
 Sulforaphane as a treatment for COVID-19
|
| Vol. 16, No. 21 |
April 3, 2020 |
Rationale for Vitamin C Treatment of COVID-19 and Other Viruses
Justification du traitement à la vitamine C du COVID 19 et d'autres virus
Zur Begründung der Vitamin-C-Therapie bei COVID-19 und anderen viralen Infekten
Motivazioni a supporto dell’impiego della Vitamina C per il COVID-19 e gli altri virus
|
| Vol. 16, No. 20 |
March 22, 2020 |
Published Research and Articles on Vitamin C as a Consideration for Pneumonia, Lung Infections, and the Novel Coronavirus (SARS-CoV-2/COVID-19)
Traitement par Perfusion IV de Vitamine C à Forte Dose du virus COVID-19
Veröffentlichte Studien und Artikel zum Einsatz von Vitamin C bei Pneumonie, Lungeninfekten und dem neuartigen Coronavirus (SARS-CoV-2/COVID-19)
Ricerche e articoli pubblicati sulla vitamina C riguardanti polmonite, infezioni polmonari e il nuovo coronavirus (SARS-CoV-2 / COVID-19)
 Estudios y artÃculos publicados sobre la vitamina C, considerando la neumonÃa, las infecciones pulmonares y el nuevo coronavirus (SARS CoV 2/COVID 19)
|
| Vol. 16, No. 19 |
March 21, 2020 |
High-dose Intravenous Vitamin C Treatment for COVID-19
Traitement par Perfusion IV de Vitamine C Ã Forte Dose du virus COVID 19
Intravenöse Vitamin-C-Hochdosis-Therapie für COVID-19
|
| Vol. 16, No. 18 |
March 18, 2020 |
Successful High-Dose Vitamin C Treatment of Patients with Serious and Critical COVID-19 Infection
Succès du traitement de vitamine C à forte dose de patients atteints d'une infection grave et critique par CoViD-19
Erfolgreiche Hochdosis-Vitamin-C-Behandlung von Patienten mit schwerer und kritischer COVID-19-Infektion
Successo nel trattamento con vitamina C ad alte dosi in pazienti con infezione COVID-19 da moderata a grave
|
| Vol. 16, No. 17 |
March 5, 2020 |
Vitamin C Saves Wuhan Family from COVID-19
La vitamine C sauve une famille de Wuhan du COVID-19
Vitamin C rettet Familie in Wuhan vor COVID-19
La vitamina C salva una famiglia di Wuhan dal COVID-19
|
| Vol. 16, No. 16 |
March 3, 2020 |
Shanghai Government Officially Recommends Vitamin C for COVID-19
Le gouvernement de Shanghai recommande officiellement la vitamine C pour COVID-19
Die Regierung von Shanghai empfiehlt offiziell Vitamin C für COVID-19
Il governo di Shanghai raccomanda ufficialmente la vitamina C per il COVID-19
|
| Vol. 16, No. 15 |
March 1, 2020 |
News Media Attacks Vitamin C Treatment of COVID-19 Coronavirus
Les Medias s'attaquent au Traitement à la Vitamine C contre le Coronavirus COVID-19
Medien greifen Vitamin-C-Behandlung des COVID-19-Coronavirus an
I Media attaccano il trattamento con vitamina C del coronavirus COVID-19
|
| Vol. 16, No. 14 |
February 28, 2020 |
Vitamin C and COVID-19 Coronavirus
Vitamine C et COVID 19 Coronavirus
Vitamin C und das COVID-19-Coronavirus
La Vitamina C e il Coronavirus COVID-19
La Vitamina C y el Coronavirus COVID-19
|
| Vol. 16, No. 13 |
February 23, 2020 |
TONS OF VITAMIN C TO WUHAN: China Using Vitamin C against COVID
Des TONNES de VITAMINE C vers WUHAN
Tonnen von Vitamin C für Wuhan
TONNELLATE di VITAMINA C verso WUHAN
|
| Vol. 16, No. 12 |
February 21, 2020 |
Three Intravenous Vitamin C Research Studies Approved for Treating COVID-19
Trois études de recherche sur la vitamine C par voie IV, approuvées pour le traitement de la COVID 19
Drei Studien über intravenöses Vitamin C zur Behandlung von COVID-19 genehmigt
|
| Vol. 16, No. 11 |
February 16, 2020 |
Early Large Dose Intravenous Vitamin C is the Treatment of Choice for 2019-nCov Pneumonia
La Vitamine C Intraveineuse (IVC) Précoce à Forte Dose est le Traitement de Choix de la Pneumonie à 2019 nCov
Frühzeitige intravenöse Vitamin-C-Hochdosistherapie ist die Behandlung der Wahl der 2019-nCov-Pneumonie
|
| Vol. 16, No. 10 |
February 13, 2020 |
Coronavirus Patients in China to be Treated with High-Dose Vitamin C
Les patients atteints de coronavirus en Chine seront traités avec une forte dose de vitamine C
Coronavirus-Patienten in China sollen mit hochdosiertem Vitamin C behandelt werden
|
| Vol. 16, No. 09 |
February 10, 2020 |
VITAMIN C AND ITS APPLICATION TO THE TREATMENT OF nCoV CORONAVIRUS: How Vitamin C Reduces Severity and Deaths from Serious Viral Respiratory Diseases
LA VITAMINE C ET SON APPLICATION DANS LE TRAITEMENT du CORONAVIRUS nCoV
Vitamin C und seine Anwendung zur Therapie des nCov-Coronavirus
|
| Vol. 16, No. 07 |
February 2, 2020 |
Hospital-based Intravenous Vitamin C Treatment for Coronavirus and Related Illnesses
Traitement intraveineux à la vitamine C, en milieu hospitalier pour les coronavirus et les maladies connexes
Klinische intravenöse Vitamin-C-Therapie bei Coronavirus und verwandten Erkrankungen
Tratamiento intravenoso de vitamina C en hospitales para los coronavirus y enfermedades relacionadas
|
| Vol. 16, No. 06 |
January 30, 2020 |
Nutritional Treatment of Coronavirus
Traitement nutritionnel du Coronavirus
Ernährungstherapie des Coronavirus
|
| Vol. 16, No. 04 |
January 26, 2020 |
Vitamin C Protects Against Coronavirus
La Vitamine C protège contre les Coronavirus
Vitamin C schützt vor Coronavirus
La vitamina C protegge dal coronavirus
|
Nutritional Medicine is Orthomolecular Medicine
Orthomolecular medicine uses safe, effective nutritional therapy to fight illness. For more information: http://www.orthomolecular.org
Find a Doctor
To locate an orthomolecular physician near you: http://orthomolecular.org/resources/omns/v06n09.shtml
The peer-reviewed Orthomolecular Medicine News Service is a non-profit and non-commercial informational resource.
Editorial Review Board:
Ilyès Baghli, M.D. (Algeria)
Ian Brighthope, MBBS, FACNEM (Australia)
Prof. Gilbert Henri Crussol (Spain)
Carolyn Dean, M.D., N.D. (USA)
Damien Downing, M.D. (United Kingdom)
Michael Ellis, M.D. (Australia)
Martin P. Gallagher, M.D., D.C. (USA)
Michael J. Gonzalez, N.M.D., D.Sc., Ph.D. (Puerto Rico)
William B. Grant, Ph.D. (USA)
Tonya S. Heyman, M.D. (USA)
Suzanne Humphries, M.D. (USA)
Ron Hunninghake, M.D. (USA)
Robert E. Jenkins, D.C. (USA)
Bo H. Jonsson, M.D., Ph.D. (Sweden)
Jeffrey J. Kotulski, D.O. (USA)
Peter H. Lauda, M.D. (Austria)
Thomas Levy, M.D., J.D. (USA)
Homer Lim, M.D. (Philippines)
Stuart Lindsey, Pharm.D. (USA)
Victor A. Marcial-Vega, M.D. (Puerto Rico)
Charles C. Mary, Jr., M.D. (USA)
Mignonne Mary, M.D. (USA)
Jun Matsuyama, M.D., Ph.D. (Japan)
Joseph Mercola, D.O. (USA)
Jorge R. Miranda-Massari, Pharm.D. (Puerto Rico)
Karin Munsterhjelm-Ahumada, M.D. (Finland)
Tahar Naili, M.D. (Algeria)
W. Todd Penberthy, Ph.D. (USA)
Dag Viljen Poleszynski, Ph.D. (Norway)
Selvam Rengasamy, MBBS, FRCOG (Malaysia)
Jeffrey A. Ruterbusch, D.O. (USA)
Gert E. Schuitemaker, Ph.D. (Netherlands)
T.E. Gabriel Stewart, M.B.B.CH. (Ireland)
Hyoungjoo Shin, M.D. (South Korea)
Thomas L. Taxman, M.D. (USA)
Jagan Nathan Vamanan, M.D. (India)
Garry Vickar, MD (USA)
Ken Walker, M.D. (Canada)
Raymond Yuen, MBBS, MMed (Singapore)
Anne Zauderer, D.C. (USA)
Andrew W. Saul, Ph.D. (USA), Editor-In-Chief
Editor, Japanese Edition: Atsuo Yanagisawa, M.D., Ph.D. (Japan)
Editor, Chinese Edition: Richard Cheng, M.D., Ph.D. (USA)
Robert G. Smith, Ph.D. (USA), Associate Editor
Helen Saul Case, M.S. (USA), Assistant Editor
Michael S. Stewart, B.Sc.C.S. (USA), Technology Editor
Jason M. Saul, JD (USA), Legal Consultant
Comments and media contact: drsaul@doctoryourself.com OMNS welcomes but is unable to respond to individual reader emails. Reader comments become the property of OMNS and may or may not be used for publication.
Click here to see a web copy of this news release: https://orthomolecular.acemlna.com/p_v.php?l=1&c=155&m=159&s=bad97c655476f96a390a72c05a742011
|
